Why Bristol Myers Squibb Jumped Nearly 10% on Friday

The pharmaceutical company is faring far better than most investors were anticipating at this point.Bristol Myers Squibb (BMY 9.94%) shareholders are certainly finishing the trading week on a high note. The drugmaker's stock is up 9.6% as of 1:14 p.m. ET, according to data from S&P Global Market Intelligence, in response to a surprisingly strong second-quarter report and subsequently raised full-year guidance.Bristol Myers Squibb is firing on all cylindersGive credit to Bristol Myers Squibb's newer drugs li ...